BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12845647)

  • 1. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.
    Garcia-Lora A; Algarra I; Gaforio JJ; Ruiz-Cabello F; Garrido F
    Int J Cancer; 2001 Jan; 91(1):109-19. PubMed ID: 11149409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
    Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
    Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway.
    Chen M; Tabaczewski P; Truscott SM; Van Kaer L; Stroynowski I
    J Immunol; 2005 Jul; 175(2):1047-55. PubMed ID: 16002705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.
    Hallermalm K; Seki K; Wei C; Castelli C; Rivoltini L; Kiessling R; Levitskaya J
    Blood; 2001 Aug; 98(4):1108-15. PubMed ID: 11493458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.
    Johnsen A; France J; Sy MS; Harding CV
    Cancer Res; 1998 Aug; 58(16):3660-7. PubMed ID: 9721876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.
    Khan AN; Gregorie CJ; Tomasi TB
    Cancer Immunol Immunother; 2008 May; 57(5):647-54. PubMed ID: 18046553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
    Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
    Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human cancers deficient in antigen processing.
    Restifo NP; Esquivel F; Kawakami Y; Yewdell JW; Mulé JJ; Rosenberg SA; Bennink JR
    J Exp Med; 1993 Feb; 177(2):265-72. PubMed ID: 8426105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of MHC-1 antigen processing machinery by down-regulation in expression of IGF-1 in human glioblastoma cells.
    Pan Y; Trojan J; Guo Y; Anthony DD
    PLoS One; 2013; 8(3):e58428. PubMed ID: 23526983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.